New biologics offer to treat a range of conditions but also come with some downplayed risks
Dr. Aldo Calvo, Medical Director of Family Medicine at Broward Health, shows a Regeneron monoclonal antibody infusion bag during a news conference at the Hospital in Fort Lauderdale, Fla., on Aug. 19, 2021. Joe Cavaretta/South Florida Sun-Sentinel via AP, File
It isn’t your imagination. More and more pharmaceutical drugs are expensive and meant to be injected, and that isn’t counting vaccines.
Biologic drugs, also called biologics, are produced from or with living organisms and are made up of blood components, cells, genes, and recombinant proteins such as those found in monoclonal antibodies.
Martha Rosenberg
Author
Martha Rosenberg is a nationally recognized reporter and author whose work has been cited by the Mayo Clinic Proceedings, Public Library of Science Biology, and National Geographic. Rosenberg’s FDA expose, "Born with a Junk Food Deficiency," established her as a prominent investigative journalist. She has lectured widely at universities throughout the United States and resides in Chicago.
